Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Aventis Plans To Launch Genasense, Ketek and Apidra In 2004

Jan 19 2004

• By The Pink Sheet

Related Content

Aventis Alvesco For Asthma Is One Of Five NDA/BLA Filings Planned For 2003

Feb 24 2003

Aventis Ketek Recommended For Pneumonia, Sinusitis, And Bronchitis

Jan 13 2003

Aventis/Regeneron VEGF Colorectal Cancer Indication Part Of $500 Mil. Deal

Sep 15 2003

Aventis/Genta Genasense Lead Indication To Be Decided This Summer

May 06 2002

Game Over: FDA Warns Aventis For Repeat Use Of Taxotere Chess-Theme Ads

Dec 15 2003

Aventis Ketek CAP Resistance Claim Needs Larger Trials, Advisory Cmte. Says

Apr 30 2001

More from Archive

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window